SCHEMBL5316909

SCHEMBL5316909

CC(C)(C)OC(=O)N1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCCO3)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 4/20 0.51
HTR3A P46098 2/20 0.51
HTR1A P08908 1/20 0.51
ADRA2C P18825 1/20 0.51
ACHE P22303 1/20 0.51
PTGS1 P23219 1/20 0.51
ADRA1A P35348 1/20 0.51
KCNH2 Q12809 1/20 0.51
EPHX1 P07099 1/20 0.45
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
LMNA P02545 1/20 0.44
PARP1 P09874 1/20 0.44
POLB P06746 1/20 0.44
HTR3E A5X5Y0 1/20 0.43
HTR3B O95264 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24001298 0.90 HTR4 (0.65) HTR4HTR3AHTR1AADRA2CACHE
SCHEMBL5316910 0.84 HTR4 (0.51) HTR4HTR3AHTR1AADRA2CACHE
SCHEMBL5316418 0.80 HDAC4 (0.45) EPHX1CNR1CNR2LMNAPARP1
SCHEMBL534970 0.78 HTR4 (0.68) HTR4HTR3AADRA2CACHEADRA1A
SCHEMBL8127466 0.77 HTR4 (0.69) HTR4HTR3AHTR1AADRA2CACHE
SCHEMBL18094596 0.77 HTR3E (0.59) HTR3ACNR1CNR2LMNAPARP1
SCHEMBL18181734 0.77 PARP1 (0.46) HTR4HTR3AHTR1AADRA2CACHE
SCHEMBL25557452 0.75 HTR4 (0.53) HTR4HTR3AHTR1AADRA2CACHE
SCHEMBL12426360 0.75 USP30 (0.52) EPHX1LMNAPARP1POLBHDAC4
SCHEMBL29268419 0.75 NPC1 (0.61) EPHX1CNR1CNR2LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007068739-A1 4-AMINO-BENZAMIDE DERIVATIVES AS 5-HT4 RECEPTOR AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL, NEUROLOGICAL AND CARDIOVASCULAR DISORDERS GLAXO GROUP LIMITED (GB) 2007-06-21 WO disclosed